"We are pleased to share the launch of Nexus' Tacrolimus Injection. Tacrolimus is a critical treatment option for patients requiring immunosuppressive therapy, enhancing their quality of life, and ...

Piperacillin and Tazobactam in the DUPLEX Drug Delivery System is one of many planned injectable drugs B. Braun will launch in the U.S. in the next several years to expand its portfolio and help meet ...

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, recently launched Piperacillin and Tazobactam, one of the most utilized injectable antibiotics in the U.S.,1 ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced two new products in its ...

Lupin receives USFDA approval for Armlupeg, a biosimilar to Neulasta, enhancing treatment options for cancer patients.

Global pharma major Lupin Limited, today announced that the United States Food and Drug Administration has approved Armlupeg™ ...

Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard ...

The U.S. Food and Drug Administration (FDA) has approved Armlupeg (pegfilgrastim-unne) 6 milligrams per 0.6 milliliter (mg/mL ...

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 ...

Drug maker Lupin on Monday said it has received approval from the US health regulator for a biosimilar indicated for the ...

Drugmaker Lupin has received U.S. Food and Drug Administration approval for Armlupeg (pegfilgrastim-unne) 6 mg/0.6 mL injection as biosimilar to Neulasta (pegfilgrastim) 6 mg/0.6 mL injection.

Lupin receives USFDA approval for Armlupeg, a biosimilar to Neulasta, used to treat neutropenia in cancer patients. Read more ...